Supernus Pharmaceuticals Inc (SUPN)
Number of days of payables
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | — | 123.56 | 103.37 | 40.54 | 44.34 | 30.54 | 12.41 | 33.64 | 40.98 | 37.30 | 45.15 | 48.40 | 42.09 | 19.80 | 34.58 | 57.35 | 17.42 | 59.25 | 44.82 | 25.09 | |
Number of days of payables | days | — | 2.95 | 3.53 | 9.00 | 8.23 | 11.95 | 29.41 | 10.85 | 8.91 | 9.79 | 8.09 | 7.54 | 8.67 | 18.44 | 10.55 | 6.36 | 20.95 | 6.16 | 8.14 | 14.55 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
Supernus Pharmaceuticals Inc's number of days of payables has been fluctuating over the past eight quarters. The trend shows a decrease in the number of days of payables from Q2 2022 to Q4 2023, indicating a more efficient management of payables. In Q4 2023, the number of days of payables stands at 8.56 days, the lowest among the quarters presented. This suggests that the company is able to pay off its obligations to suppliers and vendors more quickly in the most recent quarter. Overall, a decreasing trend in the number of days of payables can indicate improved liquidity and better financial health for the company.
Peer comparison
Dec 31, 2023